Healthcare provider profile · identity verified

Ha Tran, MD

Family Practice · GLENDORA, CA · NPI 1780070318

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	558	181
Amlodipine Besylate	Amlodipine Besylate	404	127
Losartan Potassium	Losartan Potassium	310	102
Levothyroxine Sodium	Levothyroxine Sodium	282	87
Lisinopril	Lisinopril	242	75
Metformin Hcl	Metformin Hcl	200	65
Rosuvastatin Calcium	Rosuvastatin Calcium	186	65
Alendronate Sodium	Alendronate Sodium	140	54
Gabapentin	Gabapentin	125	39
Metoprolol Succinate	Metoprolol Succinate	117	35
Simvastatin	Simvastatin	115	35
Hydrochlorothiazide	Hydrochlorothiazide	106	34
Atenolol	Atenolol	90	26
Pravastatin Sodium	Pravastatin Sodium	82	28
Lovastatin	Lovastatin	79	24
Ezetimibe	Ezetimibe	75	19
Famotidine	Famotidine	75	25
Montelukast Sodium	Montelukast Sodium	70	19
Omeprazole	Omeprazole	70	23
Metoprolol Tartrate	Metoprolol Tartrate	69	21
Sertraline Hcl	Sertraline Hcl	68	23
Tamsulosin Hcl	Tamsulosin Hcl	67	18
Fluticasone Propionate	Fluticasone Propionate	64	33
Furosemide	Furosemide	53	12
Trazodone Hcl	Trazodone Hcl	45	17
Albuterol Sulfate Hfa	Albuterol Sulfate	44	21
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	41	13
Duloxetine Hcl	Duloxetine Hcl	39	14
Glipizide	Glipizide	39	15
Synthroid	Levothyroxine Sodium	39	16
Citalopram Hbr	Citalopram Hydrobromide	38	11
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	37	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	36	suppressed
Metformin Hcl Er	Metformin Hcl	36	12
Glipizide Er	Glipizide	35	14
Diclofenac Sodium	Diclofenac Sodium	34	22
Ozempic	Semaglutide	33	suppressed
Carvedilol	Carvedilol	32	12
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	32	suppressed
Tramadol Hcl	Tramadol Hcl	32	15
Alprazolam	Alprazolam	31	18
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	31	suppressed
Valsartan	Valsartan	31	suppressed
Allopurinol	Allopurinol	30	suppressed
Benazepril Hcl	Benazepril Hcl	30	11
Azithromycin	Azithromycin	28	22
Escitalopram Oxalate	Escitalopram Oxalate	28	suppressed
Prednisone	Prednisone	27	21
Ketoconazole	Ketoconazole	26	13
Spironolactone	Spironolactone	26	suppressed
Azelastine Hcl	Azelastine Hcl	22	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	22	21
Clopidogrel	Clopidogrel Bisulfate	21	suppressed
Farxiga	Dapagliflozin Propanediol	21	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	21	suppressed
Januvia	Sitagliptin Phosphate	21	suppressed
Paroxetine Hcl	Paroxetine Hcl	21	suppressed
Jardiance	Empagliflozin	20	suppressed
Finasteride	Finasteride	19	suppressed
Symbicort	Budesonide/Formoterol Fumarate	19	suppressed
Terazosin Hcl	Terazosin Hcl	19	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	19	13
Oxybutynin Chloride	Oxybutynin Chloride	18	suppressed
Sildenafil Citrate	Sildenafil Citrate	18	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	17	suppressed
Celecoxib	Celecoxib	17	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	17	suppressed
Ibuprofen	Ibuprofen	17	12
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	15	suppressed
Fenofibrate	Fenofibrate,micronized	15	suppressed
Hydrocortisone	Hydrocortisone	15	12
Pantoprazole Sodium	Pantoprazole Sodium	14	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	14	suppressed
Baclofen	Baclofen	13	suppressed
Felodipine Er	Felodipine	13	suppressed
Fenofibrate	Fenofibrate	13	suppressed
Gemfibrozil	Gemfibrozil	13	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	13	suppressed
Potassium Chloride	Potassium Chloride	13	suppressed
Clonidine Hcl	Clonidine Hcl	12	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	12	suppressed
Naproxen	Naproxen	12	suppressed
Tretinoin	Tretinoin	12	suppressed
Buspirone Hcl	Buspirone Hcl	11	suppressed
Eliquis	Apixaban	11	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	11	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error